MODELING HEALTH AND ECONOMIC OUTCOMES ASSOCIATED WITH EXENATIDE ONCE-WEEKLY VERSUS INSULIN AND PIOGLITAZONE TREATMENT FOR TYPE-2 DIABETES

被引：0
|
作者：
Gaebler, J. A. [1 ]
Soto-Campos, G. [2 ]
Alperin, P. E. [3 ]
Hoogwerf, B. J. [4 ]
Wintle, M. [1 ]
Maggs, D. [1 ]
Han, J. [1 ]
Blickensderfer, A. [5 ]
Pencek, R. [1 ]
Bruhn, D. [6 ]
Peskin, B. R. [2 ]
机构：
[1] Amylin Pharmaceut Inc, San Diego, CA USA
[2] Archimedes Inc, San Francisco, CA USA
[3] Archimedes Inc, San Diego, CA USA
[4] Eli Lilly & Co, Indianapolis, IN 46285 USA
[5] Amylin Pharmaceut Inc, Chesterfield, MO USA
[6] Eli Lilly & Co, San Diego, CA USA
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 03期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
下载
收藏
页码：A91 / A91
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial
    Bergenstal, Richard M.
    Wysham, Carol
    MacConell, Leigh
    Malloy, Jaret
    Walsh, Brandon
    Yan, Ping
    Wilhelm, Ken
    Malone, Jim
    Porter, Lisa E.
    LANCET, 2010, 376 (9739): : 431 - 439
  • [42] Efficacy and safety of once-weekly semaglutide for the treatment of type 2 diabetes
    Tan, Xueying
    Cao, Xiaojing
    Zhou, Minzhi
    Zou, Ping
    Hu, Jingbo
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2017, 26 (09) : 1083 - 1089
  • [43] Once-Weekly Dulaglutide for Treatment of Youths with Type 2 Diabetes Response
    Arslanian, Silva A.
    Cox, David
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (16): : 1530 - 1531
  • [44] Improved treatment satisfaction with once-weekly insulin icodec versus once-daily insulin degludec in basal insulin-treated type 2 diabetes (ONWARDS 2)
    Polonsky, W.
    Benamar, M.
    Carstensen, L.
    Davies, M.
    Donatsky, A. M.
    Franek, E.
    Kellerer, M.
    Goldenberg, R.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S400 - S400
  • [45] Comparison of once-weekly with twice-daily exenatide in the treatment of type 2 diabetes (DURATION-1 trial)
    Raskin, Philip
    Mohan, Alok
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (13) : 2269 - 2271
  • [46] Exenatide Once Weekly: A Review of Pharmacology and Treatment Considerations in Type 2 Diabetes
    Brunton, Stephen
    Davidson, Jaime A.
    CLINICAL THERAPEUTICS, 2016, 38 (03) : 582 - 594
  • [47] The Short-Term Cost-Effectiveness of Once-Daily Liraglutide Versus Once-Weekly Exenatide for the Treatment of Type 2 Diabetes Mellitus in the United States
    Wang, Bruce
    Roth, Joshua A.
    Nguyen, Hiep
    Felber, Eugene
    Furnback, Wes
    Garrison, Louis P.
    PLOS ONE, 2015, 10 (04):
  • [48] Efficacy and safety of exenatide once-weekly vs exenatide twice-daily in Asian patients with type 2 diabetes mellitus
    Ji, Linong
    Onishi, Yukiko
    Ahn, Chul Woo
    Agarwal, Pankaj
    Chou, Chien-Wen
    Haber, Harry
    Guerrettaz, Kelly
    Boardman, Marilyn K.
    JOURNAL OF DIABETES INVESTIGATION, 2013, 4 (01) : 53 - 61
  • [49] Efficacy and safety of once-weekly exenatide after switching from twice-daily exenatide in patients with type 2 diabetes
    Saisho, Y.
    Watanabe, Y.
    Inaishi, J.
    Kou, K.
    Yamauchi, A.
    Kanazawa, Y.
    Okubo, Y.
    Tokui, M.
    Imai, T.
    Masaoka, T.
    Irie, J.
    Meguro, S.
    Itoh, H.
    DIABETOLOGIA, 2019, 62 : S374 - S374
  • [50] Efficacy and safety of once-weekly exenatide after switching from twice-daily exenatide in patients with type 2 diabetes
    Watanabe, Yuusuke
    Saisho, Yoshifumi
    Inaishi, Jun
    Kou, Kinsei
    Yamauchi, Akira
    Kanazawa, Yasuhiko
    Okubo, Yoshiaki
    Tokui, Mikiya
    Imai, Takatoshi
    Murakami, Rie
    Tsuchiya, Tami
    Sasaki, Hironobu
    Masaoka, Tatsuhiro
    Irie, Junichiro
    Meguro, Shu
    Itoh, Hiroshi
    JOURNAL OF DIABETES INVESTIGATION, 2020, 11 (02) : 382 - 388
12345